US5496563A
(en)
*
|
1991-08-30 |
1996-03-05 |
Showa Yakuhin Kako Co., Ltd. |
Dry gel composition
|
US5605930A
(en)
*
|
1991-10-21 |
1997-02-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Compositions and methods for treating and preventing pathologies including cancer
|
EP0620001A1
(en)
*
|
1993-04-16 |
1994-10-19 |
McNEIL-PPC, INC. |
Aqueous pharmaceutical suspension and process for preparation thereof
|
FR2713931B1
(fr)
*
|
1993-12-20 |
1996-04-05 |
Laurence Paris |
Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
|
NZ272574A
(en)
*
|
1995-07-14 |
1999-02-25 |
Lilly Eli & Co Nz Ltd |
Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
|
DK0839024T3
(da)
*
|
1995-07-14 |
2004-08-16 |
Elli Lilly & Co Nz Ltd |
Ionofore antibiotiske formuleringer
|
NZ280384A
(en)
|
1995-11-02 |
1997-01-29 |
Lilly Eli & Co Nz Ltd |
Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic
|
AUPN862596A0
(en)
*
|
1996-03-12 |
1996-04-04 |
F.H. Faulding & Co. Limited |
Pharmaceutical compositions
|
CA2253260A1
(en)
|
1996-05-02 |
1997-11-13 |
Taisho Pharmaceutical Co., Ltd. |
Suspension of sparingly water-soluble acidic drug
|
US5712310A
(en)
*
|
1996-06-14 |
1998-01-27 |
Alpharma Uspd, Inc. |
Suspension of substantially water-insoluble drugs and methods of their manufacture
|
EP1210880B8
(en)
*
|
1998-10-28 |
2009-06-03 |
San-Ei Gen F.F.I., Inc. |
Compositions containing sucralose and application thereof
|
US20110189348A1
(en)
*
|
1998-10-28 |
2011-08-04 |
San-Ei Gen F.F.I., Inc. |
Compositions containing sucralose and application thereof
|
USH2044H1
(en)
|
1998-11-02 |
2002-09-03 |
Mcneil-Ppc, Inc. |
Container with retaining member
|
BR0009557A
(pt)
|
1999-04-06 |
2002-05-28 |
Ethypharm Lab Prod Ethiques |
Suspensão farmacêutica para beber de ibuprofeno
|
US6211246B1
(en)
*
|
1999-06-10 |
2001-04-03 |
Mcneil-Ppc, Inc. |
Rapidly absorbed liquid compositions
|
US6726922B1
(en)
|
1999-06-28 |
2004-04-27 |
Minu, L.L.C. |
Process and composition for temporarily suppressing pain
|
WO2001091585A2
(en)
|
2000-05-31 |
2001-12-06 |
Pepsico, Inc. |
Low-staining orange food coloring composition
|
CN1446316A
(zh)
*
|
2000-08-02 |
2003-10-01 |
玛洛普有限公司 |
基于下丘脑-垂体-肾上腺轴异常的非溃疡性消化不良的诊断和处置
|
JP4204864B2
(ja)
*
|
2000-12-25 |
2009-01-07 |
ライオン株式会社 |
懸濁液の安定化方法及び安定化された懸濁液
|
ES2266084T3
(es)
*
|
2001-02-14 |
2007-03-01 |
Forte Iq B.V. |
Composicion farmaceutica que comprende una goma de xantano.
|
BR0207930A
(pt)
*
|
2001-03-05 |
2004-03-02 |
Ortho Mcneil Pharm Inc |
Composições farmacêuticas lìquidas com sabor mascarado
|
AU2002257104B2
(en)
*
|
2001-04-03 |
2006-02-09 |
Merck Sharp & Dohme Corp. |
Antifungal composition with enhanced bioavailability
|
MXPA04001026A
(es)
*
|
2001-07-31 |
2005-06-20 |
Wyeth Corp |
Formulacion de sucralosa para disimular sabores desagradables.
|
US6770263B1
(en)
*
|
2001-10-01 |
2004-08-03 |
Naturewell, Incorporated |
Compositions and methods for the treatment of aches and pains
|
US20040132823A1
(en)
*
|
2001-11-02 |
2004-07-08 |
Leo Pavliv |
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
ES2197781B1
(es)
*
|
2001-12-04 |
2005-02-16 |
Farmalider, S.A. |
Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
|
US7049435B2
(en)
|
2002-03-08 |
2006-05-23 |
Tate & Lyle Public Limited Company |
Extractive methods for purifying sucralose
|
US6998480B2
(en)
|
2002-03-08 |
2006-02-14 |
Tate & Lyle Public Limited Company |
Process for improving sucralose purity and yield
|
US7300670B2
(en)
|
2002-04-03 |
2007-11-27 |
Unilab Pharmatech, Ltd. |
Oral suspension formulation
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
US20040258716A1
(en)
*
|
2002-06-17 |
2004-12-23 |
Shen Gao |
Ibuprofen suspension
|
KR100509432B1
(ko)
*
|
2002-12-13 |
2005-08-22 |
주식회사 동구제약 |
S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
TWI313598B
(en)
*
|
2002-12-18 |
2009-08-21 |
Wyeth Corp |
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
|
US20040186180A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
CA2538755C
(en)
*
|
2003-09-12 |
2013-04-16 |
Ryukakusan Co. Ltd. |
Granular jelly drink capable of masking bitterness
|
US20050069590A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
US20050095299A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
US20050095300A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
US20060087051A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US8383159B2
(en)
*
|
2004-10-27 |
2013-02-26 |
Mcneil-Ppc, Inc. |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088593A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20070281022A1
(en)
*
|
2004-10-27 |
2007-12-06 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088586A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088587A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20070190133A1
(en)
*
|
2004-10-27 |
2007-08-16 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060093630A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
US20060093631A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
US20060094760A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Fawzy Abdel A |
Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
|
US7611695B2
(en)
*
|
2004-11-15 |
2009-11-03 |
Ultradent Products, Inc. |
Flavored hemostatic and acid etching compositions
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
PL2522365T3
(pl)
|
2004-11-24 |
2017-05-31 |
Meda Pharmaceuticals Inc. |
Kompozycje zawierające azelastynę i sposoby ich zastosowania
|
AU2005313365A1
(en)
|
2004-12-06 |
2006-06-15 |
Janssen Pharmaceutica N.V. |
Oral suspension comprising meloxicam
|
EP2428205B1
(en)
|
2006-03-16 |
2012-10-03 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
GB2438287A
(en)
*
|
2006-05-19 |
2007-11-21 |
Norbrook Lab Ltd |
Stable aqueous suspension
|
US20080014275A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Buehler Gail K |
Pharmaceutical suspensions and related methods
|
WO2008064192A2
(en)
|
2006-11-21 |
2008-05-29 |
Mcneil-Ppc, Inc. |
Modified release analgesic suspensions
|
WO2008109018A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
ES2463485T3
(es)
*
|
2007-03-09 |
2014-05-28 |
Hercules Incorporated |
Suspensiones estables de polímero fluidizado basadas en tiosulfato de sodio de hidroxietilcelulosa para servicios de campo de petróleo
|
US20080260837A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Qpharma, L.L.C. |
Physically stable aqueous suspensions of active pharmaceuticals
|
US20080268025A1
(en)
*
|
2007-04-25 |
2008-10-30 |
Donald Spector |
Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
US20090162923A1
(en)
*
|
2007-12-20 |
2009-06-25 |
Young Jeffrey W |
Methods and Compositions for Digestion of Organic Waste
|
BRPI0821871A2
(pt)
*
|
2008-01-03 |
2015-06-16 |
Wockhardt Research Center |
Suspensão farmacêutica oral compreendendo paracetamol e ibuprofeno
|
AR070082A1
(es)
*
|
2008-01-04 |
2010-03-10 |
Tate & Lyle Technology Ltd |
Metodo para la produccion de sucralosa
|
KR20100130219A
(ko)
*
|
2008-03-20 |
2010-12-10 |
테이트 앤드 라일 테크놀러지 리미티드 |
3급 아미드 용매로부터 산을 제거하는 방법
|
US8436157B2
(en)
*
|
2008-03-26 |
2013-05-07 |
Tate & Lyle Technology Limited |
Method for the production of sucralose
|
US8212022B2
(en)
*
|
2008-04-03 |
2012-07-03 |
Tate & Lyle Technology Limited |
Effect of carbohydrate concentration on sucralose extraction efficiency
|
AR071134A1
(es)
*
|
2008-04-03 |
2010-05-26 |
Tate & Lyle Technology Ltd |
Cristalizacion de sucralosa a partir de chorros que contienen sucralosa
|
US20090259036A1
(en)
*
|
2008-04-03 |
2009-10-15 |
Tate & Lyle Technology Limited |
Extraction of less polar impurities from sucralose containing aqueous feed streams
|
US20090299055A1
(en)
*
|
2008-04-03 |
2009-12-03 |
Tate & Lyle Technology Limited |
Purification of Sucralose Containing Feed Streams for Sucralose Crystallization
|
US8497367B2
(en)
*
|
2008-04-03 |
2013-07-30 |
Tate & Lyle Technology Limited |
Sucralose purification process
|
KR101634833B1
(ko)
|
2008-10-22 |
2016-06-29 |
어레이 바이오파마 인크. |
TRK 키나아제 억제제로서 치환된 피라졸로[1,5a] 피리미딘 화합물
|
MX357919B
(es)
*
|
2009-03-13 |
2018-07-25 |
Nucitec Sa De Cv |
Composición farmacéutica para el tratamiento de la hipercolesterolemia.
|
GB2469158B
(en)
|
2009-03-31 |
2011-09-28 |
Peter J Seaberg |
Base-assisted formation of tin-sucrose adducts
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
GB2474311B
(en)
|
2009-10-12 |
2012-10-17 |
Tate & Lyle Technology Ltd |
Low temperature, single solvent process for the production of sucrose-6-ester
|
GB2474310B
(en)
|
2009-10-12 |
2012-02-29 |
Tate & Lyle Technology Ltd |
Process for the production of sucrose-6-ester
|
GB201110520D0
(en)
|
2011-05-10 |
2011-08-03 |
Tate & Lyle Technology Ltd |
Extraction of carboxylic acids with tin compounds
|
US20150315466A1
(en)
|
2014-05-05 |
2015-11-05 |
Cal Safe Soil, Llc |
Nutrient rich compositions
|
DK3699181T3
(da)
|
2014-11-16 |
2023-03-20 |
Array Biopharma Inc |
Krystallinsk form af (s)-n-(5-((r)-2-(2,5-difluorphenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamidhydrogensulfat
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
BR112018008357A2
(pt)
|
2015-10-26 |
2018-11-27 |
Array Biopharma Inc |
mutações de ponto em câncer resistente a inibidor de trk e métodos relacionados às mesmas
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
RU2751767C2
(ru)
|
2016-04-04 |
2021-07-16 |
Локсо Онколоджи, Инк. |
Жидкие составы (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида
|
LT3458456T
(lt)
|
2016-05-18 |
2021-02-25 |
Loxo Oncology, Inc. |
(s)-n-(5-((r)-2-(2,5-difluorfenil)pirolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamido gavimas
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
JP7182794B2
(ja)
*
|
2017-08-31 |
2022-12-05 |
国立大学法人東北大学 |
リンパ行性薬剤送達法に有効な薬剤を含む溶液の適正な浸透圧域
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
WO2019084285A1
(en)
*
|
2017-10-26 |
2019-05-02 |
Qian Zhao |
FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR
|
GB2585825B
(en)
*
|
2019-07-09 |
2023-03-22 |
Lexon Uk Holdings Ltd |
Suspending vehicle formulation
|
CN112516083B
(zh)
*
|
2020-12-15 |
2023-02-28 |
太阳升(亳州)生物医药科技有限公司 |
布洛芬混悬液及其制备方法
|